New board member at Oxygen Biotherapeutics
This article was originally published in Scrip
Executive Summary
Melville Engel has joined the board of Oxygen Biotherapeutics. Mr Engel has 27 years' experience in leading large and small companies, and previously served in senior executive positions with Merck Generics Group, a division of Merck KGaA, and Allergan.